Eyewire News: The Podcast
04.23.25
The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
11.18.25
Live Coverage of B+L Investor DayShow More